EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Habitual intake of advanced glycation endproducts is not associated with worse insulin sensitivity, worse beta cell function, or presence of prediabetes or type 2 diabetes: The Maastricht Study

Armand M A Linkens, Simone J M P Eussen, Alfons J H M Houben, Andrea Mari, Pieter C Dagnelie, Coen D A Stehouwer, Casper G Schalkwijk

Clinical Nutrition · 2023

DOI: 10.1016/j.clnu.2023.05.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Nutrition, 2023. Verfasst von Armand M A Linkens und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Maastricht University Medical Center, 6229ER, Maastricht, the Netherlands; CARIM School for Cardiovascular Diseases,…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Prediabetic State, Insulin Resistance. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stichting De Weijerhorst, European Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: A diet high in advanced glycation endproducts (AGEs) is a potential risk factor for insulin resistance, beta cell dysfunction, and ultimately type 2 diabetes. We investigated associations between habitual intake of dietary AGEs and glucose metabolism in a population-based setting. METHODS: In 6275 participants of The Maastricht Study (mean ± SD age: 60 ± 9, 15.1% prediabetes and 23.2% type 2 diabetes), we estimated habitual intake of dietary AGEs Nε-(carboxymethyl)lysine (CML), Nε-(1-carboxyethyl)lysine (CEL), and Nδ-(5-hydro-5-methyl-4-imidazolon-2-yl)-ornithine (MG-H1) by combining a validated food frequency questionnaire (FFQ) with our mass-spectrometry dietary AGE database. We determined insulin sensitivity (Matsuda- and HOMA-IR index), beta cell function (C-peptidogenic index, glucose sensitivity, potentiation factor, and rate sensitivity), glucose metabolism status, fasting glucose, HbA1c, post-OGTT glucose, and OGTT glucose incremental area under the curve. Cross-sectional associations between habitual AGE intake and these outcomes were investigated using a combination of multiple linear regression and multinomial logistic regression adjusting for several potential confounders (demographic, cardiovascular, and lifestyle factors). RESULTS: Generally, higher habitual intake of AGEs was not associated with worse indices of glucose metabolism, nor with increased presence of prediabetes or type 2 diabetes. Higher dietary MG-H1 was associated with better beta cell glucose sensitivity. CONCLUSIONS: The present study does not support an association of dietary AGEs with impaired glucose metabolism. Whether higher intake of dietary AGEs translates to increased incidence of prediabetes or type 2 diabetes on the long term should be investigated in large prospective cohort studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Prediabetic StateInsulin ResistanceHumansCross-Sectional StudiesProspective StudiesGlycation End Products, AdvancedGlucoseDietary Advanced Glycation End Products

Stichwörter der Autor:innen

Beta cell functionDietary advanced glycation endproductsGlucose metabolismInsulin sensitivityPopulation-based observational cohort

Substanzen

Glycation End Products, AdvancedGlucoseDietary Advanced Glycation End Products

Autor:innen und Institutionen

  • Department of Internal Medicine, Maastricht University Medical Center, 6229ER, Maastricht, the Netherlands; CARIM School for Cardiovascular Diseases, Maastricht University, 6229ER, Maastricht, the Netherlands.
  • CARIM School for Cardiovascular Diseases, Maastricht University, 6229ER, Maastricht, the Netherlands; Department of Epidemiology, Maastricht University, 6229HA, Maastricht, the Netherlands; CAPHRI School for Care and Pu…
  • Institute of Neuroscience, National Research Council, 35131, Padova, PD, Padua, Italy.
  • Department of Epidemiology, Maastricht University, 6229HA, Maastricht, the Netherlands.
  • Department of Internal Medicine, Maastricht University Medical Center, 6229ER, Maastricht, the Netherlands; CARIM School for Cardiovascular Diseases, Maastricht University, 6229ER, Maastricht, the Netherlands. Electroni…

Förderung

  • Stichting De Weijerhorst
  • European Regional Development Fund

Zitieren

APA

Linkens, A. M. A., Eussen, S. J. M. P., Houben, A. J. H. M., Mari, A., Dagnelie, P. C., Stehouwer, C. D. A., & Schalkwijk, C. G. (2023). Habitual intake of advanced glycation endproducts is not associated with worse insulin sensitivity, worse beta cell function, or presence of prediabetes or type 2 diabetes: The Maastricht Study. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2023.05.021

Vancouver

Linkens AMA, Eussen SJMP, Houben AJHM, Mari A, Dagnelie PC, Stehouwer CDA, et al. Habitual intake of advanced glycation endproducts is not associated with worse insulin sensitivity, worse beta cell function, or presence of prediabetes or type 2 diabetes: The Maastricht Study. Clinical Nutrition. 2023. doi:10.1016/j.clnu.2023.05.021

BibTeX
@article{Linkens2023,
  author = {Linkens, Armand M A and Eussen, Simone J M P and Houben, Alfons J H M and Mari, Andrea and Dagnelie, Pieter C and Stehouwer, Coen D A and Schalkwijk, Casper G},
  title = {Habitual intake of advanced glycation endproducts is not associated with worse insulin sensitivity, worse beta cell function, or presence of prediabetes or type 2 diabetes: The Maastricht Study},
  journal = {Clinical Nutrition},
  year = {2023},
  doi = {10.1016/j.clnu.2023.05.021}
}
Kostenlos starten →